Skip to contentClarengateINTELLIGENCE
Companies/04549890

Plasticell Limited

Manufacture of flat glass · London

ActiveUnited KingdomIncorporated 2002Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2020-10-31

IXBRL · 138 source facts · 27 selected values

Not assessed
legacy record
Reporting period
2019-11-01 to 2020-10-31
Extraction status
Legacy / not assessed
Numeric facts
95
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0093_04549890_20201031
Source archive
Accounts_Monthly_Data-August2021.zip

Accounts to 2013-10-31

IXBRL · 86 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2012-11-01 to 2013-10-31
Extraction status
Legacy / not assessed
Numeric facts
66
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0008_04549890_20131031
Source archive
Accounts_Monthly_Data-July2014.zip

Accounts to 2012-10-31

IXBRL · 67 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2011-11-01 to 2012-10-31
Extraction status
Legacy / not assessed
Numeric facts
46
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-main-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_9991_04549890_20121031
Source archive
Accounts_Monthly_Data-June2013.zip

Registered details

04549890
Status
Active
Type
Private Limited Company
Incorporated
2002-10-01
Jurisdiction
—
Registered office
5, NEW STREET SQUARE, LONDON, EC4A 3TW

Classification

1 SIC codes
23110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

27 matched grants
End-User Testing of a Novel Perfusion Bioreactor for Scalable Biomanufacturing of Cell Therapies
Innovate UK · Collaborative R&D · 2025-08-01 – 2025-09-30 · with 2 other participants
£51,579
awarded
Plasticell Limited£51,579
End-User Testing of a Novel Perfusion Bioreactor for Scalable Biomanufacturing of Cell Therapies
TMF · Collaborative R&D · 2025-07-31 – 2025-09-29 · with 2 other participants
£174,032
whole project
Development of manufacture-ready GMP-grade NK-CAR therapies against solid tumoursLead
Innovate UK · Collaborative R&D · 2024-03-01 – 2026-02-28 · with 1 other participant
£188,509
awarded
Plasticell Limitedlead£188,509
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantationActive
MRC · Studentship · 2023-09-30 – 2027-09-29 · with 1 other participant
£0
whole project
Development of an integrated and scalable platform process for the robust manufacture of allogeneic iPSC immunotherapiesLead
Innovate UK · Collaborative R&D · 2022-07-01 – 2024-10-31 · with 2 other participants
£346,102
awarded
Plasticell Limitedlead£346,102
Resilience Fund (Strand 2) application for project 133873 “Pre-clinical development of a hematopoietic stem cell therapy product”Lead
Innovate UK · Collaborative R&D · 2021-12-01 – 2022-01-31
£36,540
awarded
Improved engineering and manufacture of iPSC-derived CAR-NK cells for immunotherapyLead
Innovate UK · Collaborative R&D · 2021-07-01 – 2024-05-31 · with 1 other participant
£137,692
awarded
Plasticell Limitedlead£137,692
LambdaGen Pte. Ltd (Singapore) https://www.lambdagentherapeutics.com/£0
Application for continuity grant funding for Project 133873Lead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£106,940
awarded
Pre-clinical development of a hematopoietic stem cell therapy productLead
Innovate UK · Collaborative R&D · 2020-02-01 – 2022-03-31 · with 2 other participants
£208,085
awarded
Plasticell Limitedlead£208,085
The Francis Crick Institute Limited£132,163
Anthony Nolan£131,742
Optimization of red blood cells production from iPS cells using CombiCult Technology
MRC · Studentship · 2018-08-31 – 2022-05-30 · with 1 other participant
£0
whole project
University Of EdinburghleadPlasticell Ltd
Development of advanced technologies for gene therapy manufactureLead
Innovate UK · Collaborative R&D · 2018-06-01 – 2020-11-30 · with 1 other participant
£490,731
awarded
Plasticell Limitedlead£490,731
A combinatorial approach to generate blood cells from hPSCsLead
Innovate UK · Collaborative R&D · 2017-04-01 – 2019-03-31 · with 1 other participant
£499,427
awarded
Plasticell Limitedlead£499,427
University of Edinburgh£421,011
Regulating The Self Renewal and Differentiation of Haematopoietic Stem and Progenitor Cells
MRC · Studentship · 2015-09-30 – 2019-09-29 · with 1 other participant
£0
whole project
University Of OxfordleadPlasticell Ltd
Ex vivo expansion of cord blood and bone marrow stem cellsLead
Innovate UK · Collaborative R&D · 2015-09-01 – 2019-02-28 · with 2 other participants
£543,950
awarded
Plasticell Limitedlead£543,950
Oxford University (Dept. Engineering Science)£398,543
Biocompatible Sterilisable Worm Gels: An Enabling Technology for the Development of Pluripotent Human Stem Cell-based Therapies
EPSRC · Research Grant · 2014-09-29 – 2018-09-27 · with 2 other participants
£676,383
whole project
Optimisation of human iPS cell-derived platelet manufactureLead
Innovate UK · Feasibility Studies · 2014-07-01 – 2015-09-30
£149,796
awarded
Improved Delivery and Function of Myoblasts via Soluble TIPS Microcarriers
MRC · Research Grant · 2014-01-01 – 2016-12-31 · with 5 other participants
£475,224
whole project
University College LondonleadCook Myosite IncMerckPlasticell LtdRoyal Veterinary College (RVC)University College London
Brown adipose tissue cell therapy for obesity and diabetesLead
Innovate UK · Feasibility Studies · 2013-07-01 – 2014-06-30
£149,645
awarded
Optimising secretion of therapeutically active proteins from stem cellsLead
Innovate UK · Feasibility Studies · 2012-08-01 – 2012-11-30
£24,810
awarded
Evaluating the academic market opportunity of Plasticell's CombiCult technologyLead
Innovate UK · GRD Proof of Market · 2012-08-01 – 2012-12-31
£25,000
awarded
Dissecting the molecular mechanisms by which Bmp8b increases thermogenesis in brown adipose tissue.
BBSRC · Research Grant · 2012-05-31 – 2015-05-30 · with 5 other participants
£579,129
whole project
University Of CambridgeleadEMBL European Bioinformatics Institute (EMBL - EBI)European CommissionNewcastle UniversityPlasticell LtdUniversity of Barcelona
Quantitative mapping of the proteomes of therapeutic stem cells
Innovate UK · Collaborative R&D · 2012-03-01 – 2014-02-28 · with 2 other participants
£50,717
awarded
Plasticell Limited£50,717
High Throughput Platform for the Discovery of GMP Compatible Stem Cell Manufacturing ProtocolsLead
Innovate UK · Collaborative R&D · 2012-01-01 – 2015-09-30 · with 3 other participants
£407,255
awarded
Plasticell Limitedlead£407,255
NHS Blood and Transplant (NHSBT)£161,214
Lgc Limited£68,645
Plasticell LimitedLead
Innovate UK · Feasibility Studies · 2011-05-01 – 2011-07-31
£24,663
awarded
Lineage-specific hES reporter lines for combinatorial highthroughput screeningLead
Innovate UK · Feasibility Studies · 2010-07-01 – 2011-03-31 · with 2 other participants
£57,480
awarded
Plasticell Limitedlead£57,480
Cell Therapy Using Stem Cells and Biomimetic Biodegradeable Nanostructured Materials
Innovate UK · Collaborative R&D · 2008-10-01 – 2012-09-30 · with 2 other participants
£139,000
awarded
RepRegen Limitedlead£279,732
Plasticell Limited£139,000
A technology to ensure optimum cell performance for regenerative medicineLead
Innovate UK · Collaborative R&D · 2007-01-01 – 2010-10-31 · with 2 other participants
£405,724
awarded
Plasticell Limitedlead£405,724
The Health Protection Agency (HPA NIBSC)£318,690